Bill Text: HI SB527 | 2013 | Regular Session | Amended


Bill Title: Comprehensive Breast and Cervical Cancer Control Program; Appropriation ($)

Spectrum: Partisan Bill (Democrat 8-0)

Status: (Engrossed - Dead) 2013-03-07 - Referred to HLT, FIN, referral sheet 30 [SB527 Detail]

Download: Hawaii-2013-SB527-Amended.html

 

 

STAND. COM. REP. NO. 735

 

Honolulu, Hawaii

                  

 

RE:    S.B. No. 527

       S.D. 1

 

 

 

Honorable Donna Mercado Kim

President of the Senate

Twenty-Seventh State Legislature

Regular Session of 2013

State of Hawaii

 

Madam:

 

     Your Committee on Ways and Means, to which was referred S.B. No. 527 entitled:

 

"A BILL FOR AN ACT RELATING TO CANCER,"

 

begs leave to report as follows:

 

     The purpose and intent of this measure is to appropriate funds for the comprehensive breast and cervical cancer control program.

 

     Your Committee received written comments in support of this measure from the Hawaii Medical Association.

 

     Your Committee finds that this measure will enable the comprehensive breast and cervical cancer control program to continue providing valuable services, including screening, education, and treatment, as necessary, and conducting outreach on breast and cervical cancer awareness.

 

     Your Committee has amended this measure by:

 

(1)  Changing the appropriations to an unspecified amount;

 

(2)  Making a technical nonsubstantive amendment for the purpose of clarity; and

 

(3)  Changing the effective date of the measure to July 1, 2050, in order to facilitate continued discussion on the measure.

 

     As affirmed by the record of votes of the members of your Committee on Ways and Means that is attached to this report, your Committee is in accord with the intent and purpose of S.B. No. 527, as amended herein, and recommends that it pass Third Reading in the form attached hereto as S.B. No. 527, S.D. 1.

 

Respectfully submitted on behalf of the members of the Committee on Ways and Means,

 

 

 

____________________________

DAVID Y. IGE, Chair

 

 

 

 

feedback